DOCSLIB.ORG

The Constitutionality of Restrictions on Recreational Cannabis Advertising: Balancing Public Health and Freedom of Expression

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Constitutionality of Restrictions on Recreational Cannabis Advertising: Balancing Public Health and Freedom of Expression Western University Scholarship@Western Electronic Thesis and Dissertation Repository 12-5-2017 10:00 AM The Constitutionality of Restrictions on Recreational Cannabis Advertising: Balancing Public Health and Freedom of Expression Melanie L. McPhail The University of Western Ontairo Supervisor Jacob Shelley The University of Western Ontario Graduate Program in Law A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Laws © Melanie L. McPhail 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Constitutional Law Commons, Food and Drug Law Commons, and the Health Law and Policy Commons Recommended Citation McPhail, Melanie L., "The Constitutionality of Restrictions on Recreational Cannabis Advertising: Balancing Public Health and Freedom of Expression" (2017). Electronic Thesis and Dissertation Repository. 5099. https://ir.lib.uwo.ca/etd/5099 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract On April 20, 2016, Health Minister Jane Philpott announced that legislation legalizing recreational marijuana would be introduced in Spring 2017, with the goal of keeping marijuana out of the hands of children and profit out of the hands of criminals. Bill C-45, An Act Respecting Cannabis passed the second reading in the House of Commons, and contains restrictions on advertising cannabis, with a few exceptions. Advertising is recognized as a protected form of expression under the Charter of Rights and Freedoms, so if the government infringes on this right, they must be able to prove that it is justified in a free and democratic society, pursuant to section 1 of the Charter. The Supreme Court of Canada has twice assessed restrictions on tobacco advertising, providing a framework for assessing whether advertising restrictions pass constitutional muster. Using this framework, this thesis analyzes whether the proposed restrictions on advertising marijuana are constitutional. Keywords freedom of expression, cannabis, drug policy, charter of rights and freedoms, public health, marijuana, advertising i Acknowledgments I would first like to thank my supervisor, Professor Jacob Shelley, for his invaluable guidance, assistance, and support. His mentorship extends beyond the walls of academia, and he has consistently gone above and beyond to support my goals (or lack thereof). I most certainly would not have been here without him. I would also like to thank Paul Armstrong, for editing too many versions of the pages to follow, and for his ongoing support, especially in the moments that I thought I would never finish. To my colleagues in the Master's program in the faculty of Law at Western University, thank you for challenging me, and listening to me complain for the last year. Thank you to my friends and family for listening to me talk about cannabis for the last year. I can’t promise it will stop, but I am forever grateful for every attempt to take my mind off of my thesis. A special thank you to my mom, Linda, for forwarding me every newspaper article she found relating to cannabis. I would be remiss to not acknowledge and offer my sincerest gratitude to Milos’, The Black Walnut, and Fire Roasted Coffees for providing me with a place to write, and liquid motivation. Lastly, thank you to everyone in the Faculty of Law, specifically, Michael Coyle, Valerie Oosterveld, Mary Morris, and Mysty Clapton, for all of the assistance and support the faculty has given me. ii List of Abbreviations ACMPR – Access to Cannabis for Medical Purposes Regulations ATP – Authorization to Possess BHO- Butane Hash Oil CBD – cannabidiol CDSA – Controlled Drugs and Substances Act DPPL – Designated-Person Production License MMAR – Marihuana Medical Access Regulations MMPR – Marijuana for Medical Purposes Regulations PUPL – Personal Use Production License SCC – Supreme Court of Canada THC – delta-9-tetrahydrocannabinol WHO – World Health Organization iii List of Appendices Appendix A: Bill C-45 .......................................................................................................... 230 iv Table of Contents Abstract ..................................................................................................................................... i Acknowledgments ................................................................................................................... ii List of Abbreviations ............................................................................................................. iii List of Appendices .................................................................................................................. iv Table of Contents .................................................................................................................... v 1. Introduction ..................................................................................................................... 1 1.1. Theoretical Framework ...................................................................................................... 6 1.2. Methodology ......................................................................................................................... 8 1.2.1. Doctrinal legal analysis ................................................................................................. 8 1.2.2. Secondary Literature Analysis ...................................................................................... 9 1.2.2.1. Freedom of Expression ......................................................................................................... 9 1.2.2.2. Cannabis ................................................................................................................................ 9 1.2.2.3. Advertising .......................................................................................................................... 10 2. Introduction to Cannabis & Harms ............................................................................ 11 2.1. Introduction ....................................................................................................................... 11 2.2. The Concept of Harm in Freedom of Expression Litigation ......................................... 13 2.3. Introduction to Cannabis & Cannabinoids ..................................................................... 20 2.4. Cannabis Use in Canada ................................................................................................... 25 2.5. The Problem of Researching Cannabis ........................................................................... 28 2.6. Medical Uses of Cannabis ................................................................................................. 31 2.7. Harm & Risk ...................................................................................................................... 36 2.7.1. History of Assessing the Harm of Cannabis ............................................................... 36 2.7.2. Acute Effects............................................................................................................... 39 2.7.3. Long term Risks: Physical Health............................................................................... 40 2.7.3.1. Lungs .................................................................................................................................. 40 2.7.3.2. Immune System .................................................................................................................. 43 2.7.3.3. Cardiovascular .................................................................................................................... 43 2.7.3.4. Endocrine and Reproductive Systems ................................................................................. 44 2.7.4. Long term Risks: Cognitive Function and Mental Health Risks ................................ 45 2.7.5. Long term Risks: Fetal and Adolescent Development................................................ 51 v 2.7.6. Population Level Risks ............................................................................................... 54 2.7.6.1. Overdose ............................................................................................................................. 55 2.7.6.2. Dependence ......................................................................................................................... 56 2.7.6.3. Withdrawal .......................................................................................................................... 57 2.7.6.4. Suicide ................................................................................................................................ 58 2.7.6.5. Drugged Driving ................................................................................................................. 59 2.7.6.6. Psychosocial ........................................................................................................................ 64 2.7.6.7. Other Substance Use Disorders ........................................................................................... 66 2.7.6.8. Violence .............................................................................................................................. 68 2.7.6.9. Accidental
Load more

Recommended publications
  • Pioneering the Future of Global Cannabis June 2020
    Pioneering the Future of Global Cannabis June 2020 ©2020 TILRAY Disclaimer Investors and prospective investors should rely only on the information contained in the continuous expected; that adverse changes or developments affecting the Company’s main or planned facilities may Although management has attempted to identify important risk factors that could cause actual results to disclosure filings (the “Filings”) of Tilray Inc. (the “Company”). This presentation is qualified in its entirety have an adverse effect on the Company; that the medical cannabis industry and market may not continue differ materially from those contained in the forward-looking information in this presentation, there may by reference to, and must be read in conjunction with, the information contained in the Filings. An investor to exist or develop as anticipated or the Company may not be able to succeed in this market; that the be other risk factors not presently known to the Company or that the Company presently believes are not or prospective investor is not entitled to rely on parts of the information contained in this presentation to Company has a limited operating history and a history of net losses and that it may not achieve or maintain material that could also cause actual results or future events to differ materially from those expressed in the exclusion of others, and the Company is not authorized to provide different or additional information. profitability in the future; risks related to the Company’s current or proposed international operations; risks such forward-looking information in this presentation. There can be no assurance that such information Unless otherwise specified, all monetary amounts in this presentation are in United States dollars.
    [Show full text]
  • COURT JUSTICES, 1985-2013 Jean-Christophe Bédard-Rubin
    Paper prepared for the 2018 CPSA Annual Conference – Please do not cite nor circulate without permission HOW MUCH FRENCH DO THEY SPEAK ANYWAY? A BILINGUALISM INDEX FOR SUPREME COURT JUSTICES, 1985-2013 Jean-Christophe Bédard-Rubin & Tiago Rubin Draft paper prepared for the CPSA 2018 Annual Conference. Please do not cite nor circulate without permission. Mandatory bilingualism for Supreme Court judges tantalizes Canadian politics for at least ten years now. The advocates of judicial bilingualism have repeatedly tried (and failed) to enshrine into law the requirement for Supreme Court justices to be functionally bilingual, i.e. the ability to “read materials and understand oral argument without the need for translation or interpretation in French and English”. For them, integrating mandatory bilingualism as a legislative requirement in the appointment process is a panacea. Their opponents argue that language proficiency in French should not be a sine qua non condition for Supreme Court justiceship and that requiring it would prevent excellent candidates from being appointed. However, despite the fact that empirical statements abound on both sides, there is very little empirical evidence regarding the actual impact of unilingualism and bilingualism on Canadian judicial institutions and simply no evidence whatsoever about its impact on individual judges’ behavior. Building on our ongoing research on judicial bilingualism, in this paper we try to evaluate the level of bilingualism of individual justices. What our findings suggest is that the behavior of Francophone and Anglophone bilinguals is influenced by the linguistic competency of their colleagues. Our findings also suggest that some Anglophone justices that are deemed to be bilinguals do not behave very differently from their unilingual colleagues.
    [Show full text]
  • In Focus Cannabis Legalization 4
    IN FOCUS CANNABIS LEGALIZATION 4 2020 Developments in jurisdictions with measures regulating the non-medical use of cannabis of cannabis products for medical purposes had DEVELOPMENTS IN already been allowed in Canada as early as 1999. JURISDICTIONS WITH The objectives of the current cannabis legislation in MEASURES REGULATING Canada are to keep cannabis away from young people (under 18 years of age), to prevent criminals THE NON-MEDICAL USE from profiting from the distribution and sale of can- OF CANNABIS nabis and to safeguard public health and safety by allowing adults (aged 18 and older) legal access to As at December 2019, legal provisions had been cannabis.322 Under the constitutional division of approved in Canada, Uruguay and in 11 jurisdic- powers in Canada, the federal Government and pro- tions in the United States, including the District of vincial governments have different responsibilities.323 Columbia and the Northern Mariana Islands, to As the provinces historically developed their own allow the production and sale of cannabis products systems to regulate the sale of alcohol, a similar for non-medical use. The common feature of the approach has been applied to regulate the non-med- legislation in Canada and in the jurisdictions in the ical use of cannabis products. United States is that most of them allow for-profit To monitor the outcome of the new cannabis reg- industry to produce and sell cannabis products for ulations, the Government of Canada has invested non-medical use. There are some differences in the in a formal system that may eventually help to eval- level of regulation, its implementation and the con- uate their impact and support the further trol of the non-medical use of cannabis (see tables development of policies and programmes.
    [Show full text]
  • Court of Appeal for Ontario
    COURT OF APPEAL FOR ONTARIO CITATION: Reference re Greenhouse Gas Pollution Pricing Act, 2019 ONCA 544 DATE: 20190628 DOCKET: C65807 Strathy C.J.O., Hoy A.C.J.O., MacPherson, Sharpe and Huscroft JJ.A. IN THE MATTER OF A REFERENCE to the Court of Appeal pursuant to section 8 of the Courts of Justice Act, R.S.O. 1990, c. C.34, by Order-in-Council 1014/2018 respecting the constitutionality of the Greenhouse Gas Pollution Pricing Act, Part 5 of the Budget Implementation Act, 2018, No. 1, S.C. 2018, c. 12 Josh Hunter, Padraic Ryan and Thomas Lipton, for the Attorney General of Ontario Sharlene Telles-Langdon, Christine Mohr, Mary Matthews and Neil Goodridge, for the Attorney General of Canada William E. Gould, for the intervener Attorney General of New Brunswick J. Gareth Morley, for the intervener Attorney General of British Columbia P. Mitch McAdam, Q.C. and Alan Jacobson, for the intervener Attorney General of Saskatchewan Stuart Wuttke and Adam S.R. Williamson, for the intervener Assembly of First Nations Amir Attaran, for the intervener Athabasca Chipewyan First Nation Stewart Elgie, for the intervener Canada’s Ecofiscal Commission Joseph F. Castrilli and Richard D. Lindgren, for the interveners Canadian Environmental Law Association, Environmental Defence, and Sisters of Providence of St. Vincent de Paul Jennifer King, Michael Finley and Liane Langstaff, for the intervener Canadian Public Health Association R. Bruce E. Hallsor, Q.C., Christine Van Geyn and Aaron Wudrick, for the intervener Canadian Taxpayers Federation David Robitaille,
    [Show full text]
  • A Rare View Into 1980S Top Court
    A rare view into 1980s top court New book reveals frustrations, divisions among the judges on the Supreme Court By KIRK MAKIN JUSTICE REPORTER Thursday, December 4, 2003- Page A11 An unprecedented trove of memos by Supreme Court of Canada judges in the late 1980s reveals a highly pressured environment in which the court's first female judge threatened to quit while another judge was forced out after plunging into a state of depression. The internal memos -- quoted in a new book about former chief justice Brian Dickson -- provide a rare view into the inner workings of the country's top court, which showed itself to be badly divided at the time. The book portrays a weary bench, buried under a growing pile of complex cases and desperately worried about its eroding credibility. One faction complained bitterly about their colleagues' dithering and failure to come to grips with their responsibilities, according to memos seen for the first time by the authors of Brian Dickson: A Judge's Journey. The authors -- Mr. Justice Robert Sharpe of the Ontario Court of Appeal and University of Toronto law professor Kent Roach -- also interviewed many former judges and ex-clerks privy to the inner workings of the court at arguably the lowest point in its history. "The court was struggling with very difficult issues under very difficult circumstances at the time," Prof. Roach said yesterday. "It was a court that had an incredible amount on its plate and, in retrospect, we were well served by that court." The chief agitators were Mr. Justice Antonio Lamer and Madam Justice Bertha Wilson.
    [Show full text]
  • Alcohol, Cannabis and Impaired Driving
    ALCOHOL, CANNABIS AND IMPAIRED DRIVING July 11, 2018 R. Solomon, Distinguished University Professor, Faculty of Law, Western University; K. Mahdi, J.D. 2020, Faculty of Law, Western University; & A. Sohrevardi, J.D. 2020, Faculty of Law, Western University TABLE OF CONTENTS 2 INTRODUCTION .................................................................................................. 5 ALCOHOL ............................................................................................................... 7 PART I: ALCOHOL CONSUMPTION .......................................................................... 7 Section 1: Global ................................................................................................................. 7 Section 2: Alcohol Consumption in Canada .................................................................... 8 (a) Background Information ......................................................................................... 8 (b) Rates and Patterns of Alcohol Consumption ......................................................... 10 PART II: IMPAIRED DRIVING IN CANADA ............................................................... 15 Section 1: Rates of Driving After Alcohol Consumption ................................................ 15 Section 2: Impaired Driving Crashes ............................................................................... 17 (a) A Note on the Impaired Driving Crash Data ......................................................... 17 (b) Alcohol-Related Crash Deaths and
    [Show full text]
  • Cannabis in Canada: What the Upcoming Legalization of One of Canada’S Most Popular Drugs Means for Young People Braedon R
    LETTER Cannabis in Canada: What the upcoming legalization of one of Canada’s most popular drugs means for young people Braedon R. Paul1 Citation: UBCMJ. 2018: 9.2 (40-41) ith the Canadian legalization and regulation of cannabis slated term, some have shown residual effects lasting well beyond abstinence Wfor a debut no later than July 2018,1 many Canadians are eagerly of cannabis use,14 particularly if chronic and heavy use was initiated in awaiting the day when one of Canada’s most popular drugs2,3 can be earlier adolescence. Additionally, chronic use of smoked cannabis has legally purchased and consumed for recreational purposes. Bill C-45 been associated with symptoms of chronic bronchitis and large airway [the Cannabis Act], introduced to the House of Commons in early inflammation, while the links between smoking cannabis and lung 2017,4 is set to legalize and regulate the production, distribution, and cancer have been suggested by some but not conclusively determined.15 sale of recreational cannabis across Canada, fulfilling an election If the age limit is set too high, however, illicit sales from organized promise made by the Liberal Party of Canada [LPOC] in 2015.5 crime groups, which currently reap an estimated $7 billion annually Although many are in favour of the incoming legislation, an equally in Canada alone,16 will continue to supply the underage market—a vocal group has expressed concern over its pitfalls, particularly those substantial concern given that Canadian youth are understood to be regarding the potential impacts on Canadian youth. Given what is the highest young users of cannabis in the world3 and are more than currently understood about the effects of cannabis usage on adolescent double that of the general Canadian population.2 Inevitably, such high health, these concerns are not unwarranted.
    [Show full text]
  • Truth Commissions and Public Inquiries: Addressing Historical Injustices in Established Democracies
    TRUTH COMMISSIONS AND PUBLIC INQUIRIES: ADDRESSING HISTORICAL INJUSTICES IN ESTABLISHED DEMOCRACIES by Kim Pamela Stanton A thesis submitted in conformity with the requirements for the degree of Doctor of Juridical Science Faculty of Law University of Toronto © Copyright by Kim Pamela Stanton 2010 Truth Commissions and Public Inquiries: Addressing Historical Injustices in Established Democracies Doctor of Juridical Science Kim Pamela Stanton Faculty of Law University of Toronto 2010 ABSTRACT In recent decades, the truth commission has become a mechanism used by states to address historical injustices. However, truth commissions are rarely used in established democracies, where the commission of inquiry model is favoured. I argue that established democracies may be more amenable to addressing historical injustices that continue to divide their populations if they see the truth commission mechanism not as a unique mechanism particular to the transitional justice setting, but as a specialized form of a familiar mechanism, the commission of inquiry. In this framework, truth commissions are distinguished from other commissions of inquiry by their symbolic acknowledgement of historical injustices, and their explicit “social function” to educate the public about those injustices in order to prevent their recurrence. Given that Canada has established a Truth and Reconciliation Commission (TRC) on the Indian Residential Schools legacy, I consider the TRC’s mandate, structure and ability to fulfill its social function, particularly the daunting challenge of engaging the non-indigenous public in its work. I also provide a legal history of a landmark Canadian public inquiry, the Mackenzie Valley Pipeline Inquiry, run by Tom Berger. As his Inquiry demonstrated, with visionary leadership and ii an effective process, a public inquiry can be a pedagogical tool that promotes social accountability for historical injustices.
    [Show full text]
  • Americas Increasingly Being Used in Maritime Drug Trafficking
    E/INCB/2000/1 prevent the diversion of pharmaceuticals containing Organization of American States. At present, few narcotic drugs and psychotropic substances, as well as regions have such a mechanism. chemicals, into illicit channels. At the same time, steps 231. It is hoped that the Multilateral Evaluation must be taken to ensure that essential narcotic drugs Mechanism will soon become an effective instrument and psychotropic substances are made available to for monitoring the progress of the individual and those who need them for medical purposes. collective efforts of Governments to combat illicit 227. The Board notes that there is a proposal to trafficking in and abuse of drugs. designate the port of Zanzibar as a “free port”. Given that the coastline of the United Republic of Tanzania is part of a key drug trafficking route, the Board stresses Central America and the Caribbean that measures to suppress illicit trafficking in narcotic drugs, psychotropic substances and precursor Major developments chemicals in such “free ports” should be no less 232. Drug traffickers continue to take advantage of the stringent than those applied in other parts of the fact that the region of Central America and the country, as required under article 18 of the Caribbean is located between major drug-producing 1988 Convention. areas and significant illicit drug markets, that the 228. The Board has reviewed the follow-up by the Caribbean is comprised of hundreds of relatively small Government of Togo to the recommendations made by islands with myriads of cays and that the socio- the Board after its mission to that country in economic situation in most of the countries in the June 1995.
    [Show full text]
  • From the US Fentanyl Boom to the Mexican Opium Crisis
    Grandmaison, RL, et al. 2019. The Last Harvest? From the US Fentanyl Boom to the Mexican Opium Crisis. Journal of Illicit Economies and Development, 1(3): pp. 312–329. DOI: https://doi.org/10.31389/jied.45 RESEARCH The Last Harvest? From the US Fentanyl Boom to the Mexican Opium Crisis Romain Le Cour Grandmaison1, Nathaniel Morris2 and Benjamin Smith3 1 Paris-1 Panthéon-Sorbonne, FR 2 UCL, GB 3 University of Warwick, GB Corresponding author: Nathaniel Morris ([email protected]) For decades, farmers in the most marginalised regions of Mexico have depended for survival on the illicit cultivation of opium poppy for the US heroin market. In 2017 they could earn up to 20,000 pesos ($950–$1,050 dollars) per kilo of opium, which channelled around 19 billion pesos ($1 billion dollars) into the country’s poorest communities, sustaining regional economies, religious ceremonies, and intra-community relations while stemming out-migration to Mexican cities and the US. With the recent upsurge in fentanyl use in the US, however, the demand for Mexican heroin has fallen sharply, meaning that farmers are now being paid around 6000 to 8000 pesos ($315–415 dollars) per kilo of raw opium. Thus the total money being paid to opium producing villages has dropped to an unprecedented low of 7 billion pesos ($370 million dollars). Drawing on fieldwork conducted in two poppy-producing regions of Mexico – one in the State of Nayarit, one in the State of Guerrero – this article shows that today, farmers cannot make a profit from opium once fertilizers and other capital inputs have been taken into account; village economies are starting to dry up; and out-migration is on the up.
    [Show full text]
  • Sharing the Costs of Cannabis in Canada How the Federal and Provincial Governments Should Split Cannabis Tax Revenues by ERICH HARTMANN
    MOWAT RESEARCH #169 | AUGUST 2018 Sharing the Costs of Cannabis in Canada How the federal and provincial governments should split cannabis tax revenues BY ERICH HARTMANN MUNK SCHOOL OF GLOBAL AFFAIRS & PUBLIC POLICY Acknowledgements The author would like to thank Colin Busby, Luan Ngo and Adrienne Davidson for their valuable feedback on this report. The author would also like to thank Elaine Stam for her design work on this report as well as Reuven Shlozberg, Sunil Johal, and Andrew Parkin for their helpful contributions. All content and any remaining errors are the sole responsibility of the author. The views and opinions expressed in this report are those of the author and do not necessarily reflect the official position of any other organization or agency. Author ERICH HARTMANN Practice Lead, Intergovernmental Affairs Erich Hartmann is the Mowat Centre’s Practice Lead for Intergovernmental Affairs. Erich has a deep knowledge of intergovernmental affairs and federal fiscal issues. Previously, Erich spent 13 years in the Ontario Public Service at the Ministry of Finance in a number of policy and management roles, most recently serving as Manager of Federal-Provincial Relations. Erich holds an MPA and a BA (Hons) from Queen’s University. MOWATCENTRE.CA @MOWATCENTRE 439 UNIVERSITY AVENUE The Mowat Centre is an independent public policy think tank SUITE 2200, TORONTO, ON located at the Munk School of Global Affairs and Public Policy at M5G 1Y8 CANADA the University of Toronto. The Mowat Centre is Ontario’s non-partisan, evidence-based voice on public policy. It undertakes collaborative applied policy research, proposes innovative research-driven recommendations, and engages in public dialogue on Canada’s most important national issues.
    [Show full text]
  • Canada Archives Canada Published Heritage Direction Du Branch Patrimoine De I'edition
    "THE CHEMOPHILIC SOCIETY": ADDICTION RESEARCH AFTER THE CLASSIC PERIOD OF NARCOTIC CONTROL, 1957-1975 A Thesis Presented to The Faculty of Graduate Studies of The University of Guelph by YVAN CRAIG PRKACHIN In Partial Fulfillment of requirements for the degree of Master of Arts April, 2008 © Yvan Craig Prkachin, 2008 Library and Bibliotheque et 1*1 Archives Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington Ottawa ON K1A0N4 Ottawa ON K1A0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-41860-4 Our file Notre reference ISBN: 978-0-494-41860-4 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library permettant a la Bibliotheque et Archives and Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par Plntemet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans loan, distribute and sell theses le monde, a des fins commerciales ou autres, worldwide, for commercial or non­ sur support microforme, papier, electronique commercial purposes, in microform, et/ou autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in et des droits moraux qui protege cette these. this thesis. Neither the thesis Ni la these ni des extraits substantiels de nor substantial extracts from it celle-ci ne doivent etre imprimes ou autrement may be printed or otherwise reproduits sans son autorisation.
    [Show full text]